Table 2.
In vitro |
In vivo |
||||
---|---|---|---|---|---|
IC50 (μM) | nH | ED50 (mg/kg) | nH | Min (%) | |
To042 | 0.14 ± 0.02 | 0.9 ± 0.1 | 0.07 ± 0.02 | 1.2 ± 0.3 | 30.9 ± 4.4 |
Mexiletine | 16.9 ± 2.4 | 1.2 ± 0.2 | 7.0 ± 0.02 | 1.2 ± 0.2 | 18.0 ± 7.3 |
In vitro |
In vivo |
||||
---|---|---|---|---|---|
IC50 (μM) | nH | ED50 (mg/kg) | nH | Min (%) | |
To042 | 0.14 ± 0.02 | 0.9 ± 0.1 | 0.07 ± 0.02 | 1.2 ± 0.3 | 30.9 ± 4.4 |
Mexiletine | 16.9 ± 2.4 | 1.2 ± 0.2 | 7.0 ± 0.02 | 1.2 ± 0.2 | 18.0 ± 7.3 |